title: The Effect of Aerosol Saline on Laboratory-Induced Dyspnea.
abstract: In the 'placebo arm' of a recent study, we found that aerosol saline (sham treatment) produced substantial relief of laboratory-induced dyspnea (Breathing discomfort-BD) in nearly half the subjects. The sham intervention included a physiological change, and instructions to subjects could have produced expectation of dyspnea relief. In the present study, we attempted to discover whether the response to sham aerosol was driven by behavioral or physiological aspects of the intervention.
  
  
  
  Dyspnea (air hunger) was evoked by constraining tidal volume during graded hypercapnia. We measured [Formula: see text] versus BD relationship before and after aerosol saline. To minimize subjects' expectations of dyspnea relief, participants were clearly instructed that we would only deliver saline aerosol. In Protocol 1, we delivered aerosol saline with a ventilator (mimicking our prior study); in Protocol 2, we delivered aerosol without a ventilator.
  
  
  
  Administration of aerosol saline had little effect on BD in this group of subjects with one exception: one subject experienced appreciable reduction in BD in Protocol 1. This treatment effect was less in Protocol 2. The two most likely explanations are (a) that procedures surrounding ventilator administration of aerosol produced a psychological placebo treatment effect even though the subject knew a drug was not given; (b) there were behavioral changes in breathing undetected by our measurements of respiratory flow and volume that altered the subjects comfort.
  
  
  
  When the expectation of treatment effect is minimized, a significant reduction in dyspnea in response to saline placebo is uncommon but not impossible.
authors.affiliation: Division of Pulmonary, Critical Care & Sleep Medicine, Beth Israel Deaconess Medical Center, Rm KB26, Boston, MA, 02215, USA.|Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.
authors.forename: C R
authors.initials: CR
authors.lastname: O'Donnell
authors.affiliation: Division of Pulmonary, Critical Care & Sleep Medicine, Beth Israel Deaconess Medical Center, Rm KB26, Boston, MA, 02215, USA.
authors.forename: R W
authors.initials: RW
authors.lastname: Lansing
authors.affiliation: Division of Pulmonary, Critical Care & Sleep Medicine, Beth Israel Deaconess Medical Center, Rm KB26, Boston, MA, 02215, USA.|Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.
authors.forename: R M
authors.initials: RM
authors.lastname: Schwartzstein
authors.affiliation: Division of Pulmonary, Critical Care & Sleep Medicine, Beth Israel Deaconess Medical Center, Rm KB26, Boston, MA, 02215, USA. rbanzett@bidmc.harvard.edu.|Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA. rbanzett@bidmc.harvard.edu.
authors.forename: Robert
authors.identifier: 0000-0002-3626-5735
authors.initials: R
authors.lastname: Banzett
mesh_terms: D000280:Administration, Inhalation; D000328:Adult; D000336:Aerosols / Q000627:therapeutic use; D004417:Dyspnea / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D015990:Placebo Effect; D012965:Sodium Chloride / Q000008:administration & dosage / Q000627:therapeutic use*; D012122:Ventilators, Mechanical
chemical_list: D000336:Aerosols; D012965:Sodium Chloride
keywords: Aerosol treatment; Dyspnea; Placebo; Symptom management